131 related articles for article (PubMed ID: 10704740)
1. Gadolinium neutron-capture therapy using novel gadopentetic acid-chitosan complex nanoparticles: in vivo growth suppression of experimental melanoma solid tumor.
Tokumitsu H; Hiratsuka J; Sakurai Y; Kobayashi T; Ichikawa H; Fukumori Y
Cancer Lett; 2000 Mar; 150(2):177-82. PubMed ID: 10704740
[TBL] [Abstract][Full Text] [Related]
2. Chitosan-gadopentetic acid complex nanoparticles for gadolinium neutron-capture therapy of cancer: preparation by novel emulsion-droplet coalescence technique and characterization.
Tokumitsu H; Ichikawa H; Fukumori Y
Pharm Res; 1999 Dec; 16(12):1830-5. PubMed ID: 10644070
[TBL] [Abstract][Full Text] [Related]
3. In vitro cellular accumulation of gadolinium incorporated into chitosan nanoparticles designed for neutron-capture therapy of cancer.
Shikata F; Tokumitsu H; Ichikawa H; Fukumori Y
Eur J Pharm Biopharm; 2002 Jan; 53(1):57-63. PubMed ID: 11777753
[TBL] [Abstract][Full Text] [Related]
4. Preparation of gadopentetic acid-loaded chitosan microparticles for gadolinium neutron-capture therapy of cancer by a novel emulsion-droplet coalescence technique.
Tokumitsu H; Ichikawa H; Fukumori Y; Block LH
Chem Pharm Bull (Tokyo); 1999 Jun; 47(6):838-42. PubMed ID: 10399838
[TBL] [Abstract][Full Text] [Related]
5. Influence of the particle size of gadolinium-loaded chitosan nanoparticles on their tumor-killing effect in neutron capture therapy in vitro.
Andoh T; Nakatani Y; Suzuki M; Sakurai Y; Fujimoto T; Ichikawa H
Appl Radiat Isot; 2020 Oct; 164():109270. PubMed ID: 32819508
[TBL] [Abstract][Full Text] [Related]
6. Gadolinium-loaded chitosan nanoparticles for neutron-capture therapy: Influence of micrometric properties of the nanoparticles on tumor-killing effect.
Ichikawa H; Uneme T; Andoh T; Arita Y; Fujimoto T; Suzuki M; Sakurai Y; Shinto H; Fukasawa T; Fujii F; Fukumori Y
Appl Radiat Isot; 2014 Jun; 88():109-13. PubMed ID: 24462286
[TBL] [Abstract][Full Text] [Related]
7. In vivo evaluation of neutron capture therapy effectivity using calcium phosphate-based nanoparticles as Gd-DTPA delivery agent.
Dewi N; Mi P; Yanagie H; Sakurai Y; Morishita Y; Yanagawa M; Nakagawa T; Shinohara A; Matsukawa T; Yokoyama K; Cabral H; Suzuki M; Sakurai Y; Tanaka H; Ono K; Nishiyama N; Kataoka K; Takahashi H
J Cancer Res Clin Oncol; 2016 Apr; 142(4):767-75. PubMed ID: 26650198
[TBL] [Abstract][Full Text] [Related]
8. Gadolinium diethylenetriaminopentaacetic acid-loaded chitosan microspheres for gadolinium neutron-capture therapy.
Saha TK; Ichikawa H; Fukumori Y
Carbohydr Res; 2006 Dec; 341(17):2835-41. PubMed ID: 17045253
[TBL] [Abstract][Full Text] [Related]
9. Neutron capture therapy with gadopentetate dimeglumine: experiments on tumor-bearing rats.
Khokhlov VF; Yashkin PN; Silin DI; Djorova ES; Lawaczeck R
Acad Radiol; 1995 May; 2(5):392-8. PubMed ID: 9419581
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of MRI contrast agents in malignant fibrous histiocytoma for gadolinium neutron capture therapy.
Fujimoto T; Ichikawa H; Akisue T; Fujita I; Kishimoto K; Hara H; Imabori M; Kawamitsu H; Sharma P; Brown SC; Moudgil BM; Fujii M; Yamamoto T; Kurosaka M; Fukumori Y
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S355-8. PubMed ID: 19386506
[TBL] [Abstract][Full Text] [Related]
11. Long-circulating gadolinium-encapsulated liposomes for potential application in tumor neutron capture therapy.
Le UM; Cui Z
Int J Pharm; 2006 Apr; 312(1-2):105-12. PubMed ID: 16457973
[TBL] [Abstract][Full Text] [Related]
12. Gadolinium neutron capture therapy (GdNCT) of melanoma cells and solid tumors with the magnetic resonance imaging contrast agent Gadobutrol.
Hofmann B; Fischer CO; Lawaczeck R; Platzek J; Semmler W
Invest Radiol; 1999 Feb; 34(2):126-33. PubMed ID: 9951792
[TBL] [Abstract][Full Text] [Related]
13. Formulation considerations of gadolinium lipid nanoemulsion for intravenous delivery to tumors in neutron-capture therapy.
Ichikawa H; Watanabe T; Tokumitsu H; Fukumori Y
Curr Drug Deliv; 2007 Apr; 4(2):131-40. PubMed ID: 17456032
[TBL] [Abstract][Full Text] [Related]
14. Hybrid Calcium Phosphate-Polymeric Micelles Incorporating Gadolinium Chelates for Imaging-Guided Gadolinium Neutron Capture Tumor Therapy.
Mi P; Dewi N; Yanagie H; Kokuryo D; Suzuki M; Sakurai Y; Li Y; Aoki I; Ono K; Takahashi H; Cabral H; Nishiyama N; Kataoka K
ACS Nano; 2015 Jun; 9(6):5913-21. PubMed ID: 26033034
[TBL] [Abstract][Full Text] [Related]
15. Biodistribution of gadolinium incorporated in lipid emulsions intraperitoneally administered for neutron-capture therapy with tumor-bearing hamsters.
Miyamoto M; Hirano K; Ichikawa H; Fukumori Y; Akine Y; Tokuuye K
Biol Pharm Bull; 1999 Dec; 22(12):1331-40. PubMed ID: 10746166
[TBL] [Abstract][Full Text] [Related]
16. Tumor growth suppression by gadolinium-neutron capture therapy using gadolinium-entrapped liposome as gadolinium delivery agent.
Dewi N; Yanagie H; Zhu H; Demachi K; Shinohara A; Yokoyama K; Sekino M; Sakurai Y; Morishita Y; Iyomoto N; Nagasaki T; Horiguchi Y; Nagasaki Y; Nakajima J; Ono M; Kakimi K; Takahashi H
Biomed Pharmacother; 2013 Jul; 67(6):451-7. PubMed ID: 23743325
[TBL] [Abstract][Full Text] [Related]
17. Image-Guided Neutron Capture Therapy Using the Gd-DO3A-BTA Complex as a New Combinatorial Treatment Approach.
Jung KH; Park JA; Kim JY; Kim MH; Oh S; Kim HK; Choi EJ; Kim HJ; Do SH; Lee KC; Kim KM; Lee YJ; Chang Y
Contrast Media Mol Imaging; 2018; 2018():3727109. PubMed ID: 30515066
[TBL] [Abstract][Full Text] [Related]
18. Cellular uptake and in vitro antitumor efficacy of composite liposomes for neutron capture therapy.
Peters T; Grunewald C; Blaickner M; Ziegner M; Schütz C; Iffland D; Hampel G; Nawroth T; Langguth P
Radiat Oncol; 2015 Feb; 10():52. PubMed ID: 25889824
[TBL] [Abstract][Full Text] [Related]
19. Biodistribution and tumor-accumulation of gadolinium (Gd) encapsulated in long-circulating liposomes in tumor-bearing mice for potential neutron capture therapy.
Le UM; Cui Z
Int J Pharm; 2006 Aug; 320(1-2):96-103. PubMed ID: 16713149
[TBL] [Abstract][Full Text] [Related]
20. Preparation of lecithin microcapsules by a dilution method using the Wurster process for intraarterial administration in gadolinium neutron capture therapy.
Jono K; Ichikawa H; Fujioka K; Fukumori Y; Akine Y; Tokuuye K
Chem Pharm Bull (Tokyo); 1999 Jan; 47(1):54-63. PubMed ID: 9987827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
